Viralgen Vector Core and Elpida Therapeutics partner to
Trial participants with Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type 4J (CMT4J) could benefit from this joint effort to manufacture...
Stay updated with breaking news from Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trial participants with Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type 4J (CMT4J) could benefit from this joint effort to manufacture...
The market ended flat on mixed global cues and continued FII selling. About 1,791 shares advanced, 1,756 declined and 122 remained unchanged
As per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. The consensus recommendation from 3 analysts for the stock is a 'Buy'.
Nifty IT index fell 0.54% on fears of a delayed demand recovery in the US due to higher interest rates. Mphasis, Coforge, Tech Mahindra and Infosys were the top losers. Nifty Bank also declined 0.32%, dragged by Bank of Baroda, PNB and Indian Bank
Yields on US treasury bonds surged to a fresh 16-year peak overnight, tipping off a spike in the dollar index to a 10-month high of 106. Both these factors dampened sentiment for equities